Dr Martens Stock

GBP0.79

1.02% yesterday

London, Jul 15, 05:37 pm CET

ISIN

GB00BL6NGV24

Symbol

DOCS

Index

STOXX Europe 600

Sector

Consumer goods

Industry

Clothing

Overview Dividends Analysts Charts Strategies

Dr Martens Stock price

GBP0.79

-3.26 80.42% 5Y

London, Closing price Tue, Jul 15 2025

-0.00 0.56%

ISIN

GB00BL6NGV24

Symbol

DOCS

Index

STOXX Europe 600

Sector

Consumer goods

Industry

Clothing

Key metrics

Basic

Market capitalization

GBP763.0m

Enterprise Value

GBP1.0b

Net debt

GBP245.8m

Cash

GBP155.9m

Shares outstanding

963.8m

Valuation (TTM | estimate)

P/E

- | 15.2

P/S

1.0 | 0.9

EV/Sales

1.3 | 1.2

EV/FCF

5.7

P/B

2.1

Dividends

DPS

GBP0.02

Yield 1Y | 5Y

2.3% | 1.5%

Growth 1Y | 5Y

-68.5% | -

Payout 1Y | 3Y

- | 67.6%

Increased

0 Years

Financials (TTM | estimate)

Revenue

GBP787.6m | GBP849.7m

EBITDA

GBP142.4m | GBP174.1m

EBIT

GBP69.9m | GBP90.2m

Net Income

GBP4.5m | GBP49.9m

Free Cash Flow

GBP177.6m

Growth (TTM | estimate)

Revenue

-10.2% | 7.9%

EBITDA

-28.3% | 22.3%

EBIT

-44.6% | 29.1%

Net Income

-93.5% | 1,009.6%

Free Cash Flow

27.3%

Financial Health

Equity Ratio

41.2%

Return on Equity

1.2%

ROCE

9.6%

ROIC

6.1%

Debt/Equity

1.1

EPS

GBP0.0

FCF per Share

GBP0.2

Short interest

60.0%

Employees

Rev per Employee

GBP300.0k

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Get Started for Free Today

Dr Martens Stock Analysis

Unlock Scores for Free

??

12 Analysts have issued a Dr Martens forecast:

6x Buy

50%

6x Hold

50%

More details on Analyst Estimates Including Price Targets

12 Analysts have issued a Dr Martens forecast:

Buy

50%

Hold

50%

Analyst Estimates with Stock Price Targets

Financial data from Dr Martens

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	788 788	10% 10% 100%
- Direct Costs	276 276	9% 9% 35%
Gross Profit	512 512	11% 11% 65%
- Selling and Administrative Expenses	370 370	2% 2% 47%
- Research and Development Expense	- -	- -
EBITDA	142 142	28% 28% 18%
- Depreciation and Amortization	73 73	0% 0% 9%
EBIT (Operating Income) EBIT	70 70	45% 45% 9%
Net Profit	4.50 4.50	93% 93% 1%

In millions GBP.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.

Head office	United Kingdom
CEO	Ije Nwokorie
Employees	2,630
Founded	1945
Website	www.drmartensplc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now